1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Spinal Cord Injury Research Program (SCIRP) Anticipated Funding Opportunities for Fiscal Year 2026 (FY26) is sponsored by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). The SCIRP funds research and development efforts to advance the treatment and management of spinal cord injury (SCI) and ameliorate its consequences.
The program emphasizes the involvement of individuals with lived SCI experience in the research process.
Get alerted about grants like this
Save a search for “Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Press Release: 2026 Spinal Cord Injury Research Program, Congressionally Directed Medical Research Program You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Lapse in Federal Appropriations The most recent appropriations for the Department of War expired at 11:59 p. m. EST on September 30, 2025.
Military personnel will continue in a normal duty status without pay until such time as a continuing resolution or appropriations are passed by Congress and signed into law. Civilian personnel not engaged in excepted activities will be placed in a non-work, non-pay status. Visit www.
dha. mil/shutdown for more information.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research 2026 Spinal Cord Injury Research Program Released: February 17, 2026 Defense Health Agency Research and Development Medical Research and Development Command Congressionally Directed Medical Research Programs Spinal Cord Injury Research Program For FY26, the SCIRP identified near-term and long-term goals for program-supported research outcomes and products, which align to four key priority areas within the SCI field.
Research supported by the FY26 SCIRP must address at least one of the program priority areas and an associated near-team goal listed below. Additionally, applications must describe the steps the research team will take to further advance the research outcome/product in accordance with the long-term goal of the same priority area.
Priority Area: Acute Injury Intervention Near-Term Goal: Develop and test interventions, e.g., surgical, device, pharmacologic, to preserve and/or protect spinal cord tissue within a clinically feasible timeframe for improved neurologic outcomes relevant to the civilian and/or battlefield/deployed environment Long-Term Goal: Adoption of acute SCI management/stabilization practices within the battlefield, pre-hospital or hospital environments that meaningfully improve outcomes Priority Area: Secondary Health Effects Near-Term Goal: Develop and test interventions to address secondary health effects of SCI that impact injury survivors throughout their full lifespan Long-Term Goal: Adoption of interventions that address secondary health effects of SCI Priority Area: Psychosocial issues Near-Term Goal: Develop and test interventions that address psychosocial issues and that are specifically tailored for people with SCI, their families and/or their care-partners.
Long-Term Goal: Adoption of interventions that promote psychosocial well-being for people with SCI, their families and/or their care-partners.
Priority Area: Rehabilitation and Regeneration Near-Term Goal A: Develop and test rehabilitation strategies that meaningfully improve functional recovery after SCI Near-Term Goal B: Develop and test regenerative/neuroplastic interventions that meaningfully improve outcomes after SCI Long-Term Goal: Adoption of interventions/techniques that meaningfully improve outcomes after SCI Independent investigators at all career levels.
Early-Career Partnership Option Requires one early-career investigator to partner with one independent investigator at any career level. Early-career investigators are individuals with at least 3 years of independent or non-independent research experience beyond a terminal degree but no more than 7 years within their first faculty appointment or equivalent independent research position.
The early-career investigator may serve as the initiating or partnering PI. Supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of SCI. Proposed projects may range from small proof-of-concept trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant populations.
Alternative trial designs to traditional randomized clinical trials are allowed but should be appropriate to the objective of the trial. Applications must name at least two community partners who will provide advice and consultation throughout the planning and implementation of the research project. Maximum period of performance is 4 years Maximum allowable funding is $4.
8 million for total costs* Early-Career Partnership Option Maximum period of performance is 4 years Maximum allowable funding is $4. 96M for total costs* Accommodates two PIs on seperate individual awards Clinical Translation Research Award Independent investigators at all career levels. Early-Career Partnership Option Requires one early-career investigator to partner with one independent investigator at any career level.
Early-career investigators are individuals with at least 3 years of independent or non-independent research experience beyond a terminal degree but no more than 7 years within their first faculty appointment or equivalent independent research position. The early-career investigator may serve as the initiating or partnering PI.
Supports high-impact, new or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot or optimization, to prepare for larger-scale clinical trials. Primary goals of this mechanism include: Advance Clinical Practice: Translate current and emerging techniques/interventions into clinical use by de-risking and informing the design of definitive trials.
Inform Decision-Making: Identify the most effective diagnosis, treatment and rehabilitation options to support critical decision-making for patients, clinicians, care-partners and policymakers. Applications must propose clinical research or clinical trials and may not propose animal research.
Applications must name at least two community partners who will provide advice and consultation throughout the planning and implementation of the research project. Maximum period of performance is 3 years Maximum allowable funding is $2. 0M for total costs* Early-Career Partnership Option Maximum period of performance is 3 years Maximum allowable funding is $2.
16M for total costs* Accommodates two PIs on seperate individual awards Translational Research Award Independent investigators at all career levels. Early-Career Partnership Option Requires one early-career investigator to partner with one independent investigator at any career level.
Early-career investigators are individuals with at least 3 years of independent or non-independent research experience beyond a terminal degree but no more than 7 years within their first faculty appointment or equivalent independent research position. The early-career investigator may serve as the initiating or partnering PI. Supports research to accelerate the movement of promising ideas in SCI research toward clinical application.
Applications may include preclinical animal studies and/or clinical research involving human subjects and human anatomical substances. May include a pilot clinical trial ONLY as a part of the proposed research where limited clinical testing of a novel intervention or device is necessary to inform the next step in the continuum of translational research.
Applications must name at least one community partner who will provide advice and consultation throughout the planning and implementation of the research project. Maximum period of performance is 3 years Maximum allowable funding is $2. 0M for total costs* Early-Career Partnership Option Maximum period of performance is 3 years Maximum allowable funding is $2.
16M for total costs* Accommodates two PIs on seperate individual awards Investigator-Initiated Research Award Independent investigators at all career levels. Early-Career Partnership Option Requires one early-career investigator to partner with one independent investigator at any career level.
Early-career investigators are individuals with at least 3 years of independent or non-independent research experience beyond a terminal degree but no more than 7 years within their first faculty appointment or equivalent independent research position. The early-career investigator may serve as the initiating or partnering PI.
Funds research with the potential to make an important contribution to SCI research, patient care and/or quality of life. Permitted research includes preclinical studies in animal models, research with human subjects or human anatomical substances, as well as ancillary studies associated with an existing clinical trial. Preliminary data required.
Clinical trials not allowed. Maximum period of performance is 3 years Maximum allowable funding is $800,000 for total costs* Early-Career Partnership Option Maximum period of performance is 3 years Maximum allowable funding is $960,000 for total costs* Accommodates two PIs on seperate individual awards *Total costs include direct and indirect costs. dha.
detrick. cdmrp. mbx.
public-affairs@health. mil Last updated Tuesday, February 17, 2026
Based on current listing details, eligibility includes: Not explicitly detailed in the snippet, but CDMRP grants are typically open to academic, government, and private sector organizations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Funding amounts vary based on project scope and sponsor guidance. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Multiple Sclerosis Research Program (MSRP) Clinical Trial Award is sponsored by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). The MSRP CTA supports rapid implementation of clinical trials with the potential to significantly impact multiple sclerosis treatment or management. This includes evaluating new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Anticipated Funding Opportunities for Fiscal Year 2026 (FY26) is sponsored by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). The TBIPHRP funds research to understand, prevent, and treat psychological health conditions and/or traumatic brain injuries, with the goal of improving the health and healthcare of Service Members, their Families, Veterans, and the American public.
Ovarian Cancer Clinical Trial Academy - Early-Career Investigator Award (FY26) is sponsored by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). The intent of this award is to enhance knowledge within the next generation of Early-Career Investigators (ECIs) in clinical trial research and to produce effective treatments and cures for ovarian cancer. It enables the ECI to pursue funding for ovarian cancer clinical trial research under the guidance of a Designated Mentor.
Broad Agency Announcement (BAA) Call N0001425SBC03 For Office of Naval Research (ONR) Global Opportunity: GlobalX Innovation Joint Challenge: AI for Advancing Maritime Security is sponsored by Office of Naval Research (ONR) Global. This BAA Call seeks proposals for the GlobalX Innovation Joint Challenge: AI for Advancing Maritime Security. It funds the development of artificial intelligence solutions for maritime security applications, focusing on innovative AI algorithms for challenging maritime scene perception scenarios using real-world or synthetic data from UxV platforms. The program aims to accelerate the traditional knowledge generation cycle, leading to revolutionary dual-use capability for the U.S. Navy and Marine Corps and the commercial marketplace. White papers are highly encouraged and due May 23, 2025, with full proposals due June 23, 2025.
Operation Stonegarden (OPSG) is a federal grant program administered by FEMA through the Office of the Governor's Public Safety Office that funds enhanced border security cooperation among Customs and Border Protection (CBP), U.S. Border Patrol, and state, local, tribal, and territorial law enforcement agencies. The program supports joint operations to secure land and water border routes, improve intelligence sharing, and expand 287(g) screening operations within correctional facilities. In 2025, the national priority is Supporting Border Crisis Response and Enforcement, covering training, operational coordination, and risk management. Eligible expenses include operational overtime costs, staffing support for screening activities, and training programs in immigration law, civil rights protections, and 287(g) procedures.